Medical Chemical Defense (Op Sys Dev)
Abstract
This project provides for the upgrade and modernization of fielded medical nerve agent treatment system that contribute to the layered medical defenses against chemical warfare agent threats facing U.S. Forces in the field. In FY2023, the CBDP RDT&E Projects have been restructured to align to the CBDP portfolio. MC7 efforts in FY2022 progress to the Mitigate (MT7) portfolio. This restructuring is intended to provide standardization and alignment across CBDP research, development and acquisition efforts. The effort included in this Project is: (1) Improved Nerve Agent Treatment System Centrally Acting (INATS CA) **Progresses to MT7 in FY2023**
Document Details
- Document Type
- Project
- Publication Date
- Oct 01, 2024
- Source ID
- MC7_0607384BP_7_0400_PB_2024
Related Documents
- Root: Chemical and Biological Defense (Operational Systems Development)
- Child Accomplishment: 1) INATS CA
- Child Accomplishment: 2) INATS CA
- Child Cost Item: bd3b78188f25c2056757d740a894a56a
- Child Cost Item: cd2382e3d7a5f1a4ff34192aad278994
- Child Cost Item: bed99e7a572912c9a994656288b23b37